Written answers

Tuesday, 28 May 2024

Photo of Claire KerraneClaire Kerrane (Roscommon-Galway, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

471. To ask the Minister for Health the amount of funding the HSE provides to an organisation (details supplied) specifically towards patient services, excluding funding for awareness campaigns; and his views on whether this amount is sufficient to support the approximately 600,000 heart and stroke patients living in Ireland, with 80,000 people discharged with a cardiovascular condition each year. [23960/24]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Thanks to continued investment in Health Services, Ireland has seen a decline in the number of deaths from cardiovascular disease (CVD). Since 2012, the mortality rate from heart disease has been reduced by 38%, mortality from stroke has been reduced by 48%.

However, CVD remains a significant challenge claiming 9,000 lives annually.

The Government acknowledges the vital support, education, and advocacy offered by the Irish Heart Foundation and other patient support groups.

Many patient services are embedded in policy, including the National Stroke Strategy 2022-2027 for which the government has provided over €7m to date.

Partnerships and collaboration are and will continue to be, enablers of our commitment to promoting the cardiovascular health of our nation.

In 2022 and 2023, the HSE's National Heart Programme, supported through the Enhanced Community Care Programme, sponsored two CVD risk prevention projects with the IHF.

The State, via the HSE, provides funding to the IHF, and other cardiovascular support agencies of approximately €530,000 through Service Level Agreements and Grant Aid Agreements of which €380,000 was allocated to IHF in 2024.

In 2024, the HSE advise that an additional once-off sum of €400,000 has been allocated to the Irish Heart Foundation's for a High-Risk CVD Prevention Programme which has demonstrated its effectiveness by enhancing healthcare provision, clinical outcomes, and health behaviours in patients living in deprived communities.

Photo of Claire KerraneClaire Kerrane (Roscommon-Galway, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

472. To ask the Minister for Health if he will provide the funding to protect existing heart and stroke patients via community support services in the State, including those provided by an organisation (details supplied); and if he will make a statement on the matter. [23961/24]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Thanks to continued investment in Health Services, Ireland has seen a decline in the number of deaths from cardiovascular disease (CVD). Since 2012, the mortality rate from heart disease has been reduced by 38%, mortality from stroke has been reduced by 48%.

However, CVD remains a significant challenge claiming 9,000 lives annually.

The Government acknowledges the vital support, education, and advocacy offered by the Irish Heart Foundation and other patient support groups.

Many patient services are embedded in policy, including the National Stroke Strategy 2022-2027 for which the government has provided over €7m to date.

Partnerships and collaboration are and will continue to be, enablers of our commitment to promoting the cardiovascular health of our nation.

In 2022 and 2023, the HSE's National Heart Programme, supported through the Enhanced Community Care Programme, sponsored two CVD risk prevention projects with the IHF.

The State, via the HSE, provides funding to the IHF, and other cardiovascular support agencies of approximately €530,000 through Service Level Agreements and Grant Aid Agreements of which €380,000 was allocated to IHF in 2024.

In 2024, the HSE advise that an additional once-off sum of €400,000 has been allocated to the Irish Heart Foundation's for a High-Risk CVD Prevention Programme which has demonstrated its effectiveness by enhancing healthcare provision, clinical outcomes, and health behaviours in patients living in deprived communities.

Comments

No comments

Log in or join to post a public comment.